Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Clifford C. Nwaeburu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5010228028. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2013: 1 paper · 2014: 3 papers · 2015: none · 2016: 3 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. Retraction: Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Co-author DOI 10.18632/oncotarget.28751↗
  2. Correction: The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Co-author DOI 10.1038/s41419-023-06385-9↗
  3. Retraction Note: Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Co-author DOI 10.1186/s12943-023-01834-7↗
  4. [Corrigendum] Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer. First author DOI 10.3892/ijo.2023.5543↗
  5. Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer. First author DOI 10.3892/ijo.2018.4616↗
  6. Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.04.001↗
  7. Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1. Co-author DOI 10.1038/cddis.2017.455↗
  8. Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Co-author DOI 10.1186/s12943-017-0589-8↗
  9. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.01.038↗
  10. Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Co-author DOI 10.18632/oncotarget.11122↗
  11. Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.7031↗
  12. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Co-author DOI 10.1002/ijc.28583↗
  13. Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Co-author DOI 10.18632/oncotarget.1764↗
  14. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Co-author DOI 10.18632/oncotarget.2120↗
  15. The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Co-author DOI 10.1038/cddis.2013.158↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingrid Herr · 15 shared papers, 2013–2025 · strength 1.56
  2. Alia Abukiwan · 7 shared papers, 2016–2025 · strength 1.02
  3. Nathalie Bauer · 7 shared papers, 2014–2023 · strength 0.52
  4. Oliver Strobel · 4 shared papers, 2017–2023 · strength 0.39
  5. Nathalia A. Giese · 3 shared papers, 2013–2024 · strength 0.28
  6. Li Liu · 2 shared papers, 2019–2023 · strength 0.26
  7. Carina Hage · 2 shared papers, 2013–2024 · strength 0.24
  8. Pei Fan · 3 shared papers, 2014–2016 · strength 0.14
  9. Thilo Hackert · 2 shared papers, 2017–2018 · strength 0.13
  10. Yefeng Yin · 2 shared papers, 2016–2018 · strength 0.12
  11. Peter Schemmer · 3 shared papers, 2014–2016 · strength 0.12
  12. Yiyao Zhang · 3 shared papers, 2014–2016 · strength 0.12
  13. Li Liu · 2 shared papers, 2014–2017 · strength 0.10
  14. Li Liu · 2 shared papers, 2014–2016 · strength 0.08
  15. Libo Yin · 1 shared paper, 2018 · strength 0.07
  16. Jens Werner · 2 shared papers, 2014 · strength 0.07
  17. Orkhan Isayev · 2 shared papers, 2014 · strength 0.07
  18. Adam Kaczorowski · 1 shared paper, 2016 · strength 0.05
  19. Prince Saforo Amponsah · 1 shared paper, 2016 · strength 0.05
  20. Xi Xiao · 1 shared paper, 2016 · strength 0.05
  21. Alexandr V. Bazhin · 1 shared paper, 2014 · strength 0.03
  22. Felix Rückert · 1 shared paper, 2014 · strength 0.03
  23. Tobias Förster · 1 shared paper, 2014 · strength 0.03
  24. Michael Schaefer · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.